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Abstract
BioPlus 2B® is a preparation of Bacillus subtilis and Bacillus licheniformis authorised for use with
piglets, pigs and turkeys for fattening, sows and calves. The EFSA Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to re-evaluate the additive when used in feeds
for these species and to assess a new use in water for drinking. The additive subject of the evaluation
is BioPlus 2B® 10, a formulation 10-fold more concentrated than that currently authorised. The active
agents have been identiﬁed as strains of B. licheniformis and B. subtilis; they are susceptible to
relevant antibiotics and do not show toxigenic potential. Consequently, they meet the qualiﬁcations
required by the qualiﬁed presumption of safety (QPS) approach and are presumed safe for the target
species, consumers and the environment. In the absence of data, the FEEDAP Panel cannot conclude
on the irritancy of the additive to skin and eyes or its dermal sensitisation. The dustiness of BioPlus
2B® 10 indicated a potential for users to be exposed via inhalation. Given the proteinaceous nature of
the active agents, the additive should be considered as a potential respiratory sensitiser. BioPlus 2B®
and BioPlus 2B® 10 are considered equivalent when used to deliver the same dose. BioPlus 2B® has
the potential to improve performance of piglets (weaned and suckling plus weaned), pigs for fattening,
sows and calves for rearing at a minimum dose of 1.3 9 109 colony forming units (CFU)/kg complete
feed or when used in water for drinking at an equivalent dose of 6.5 9 108 CFU/L water. The additive
has the potential to reduce mortality of piglets when used over a complete reproductive cycle of sows.
No conclusion could be drawn on the efﬁcacy of BioPlus 2B® for turkeys for fattening.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7. In particular, Article 10(2) of that Regulation also speciﬁes that
for existing products within the meaning of Article 10(1), an application shall be submitted in
accordance with Article 7, at the latest 1 year before the expiry date of the authorisation given
pursuant to Directive 70/524/EEC for additives with a limited authorisation period, and within a
maximum of 7 years after the entry into force of this Regulation for additives authorised without a
time limit or pursuant to Directive 82/471/EEC.
The European Commission received a request from Chr. Hansen A/S2 for authorisation and
re-evaluation of the product BioPlus 2B® (Bacillus subtilis DSM 5750 and Bacillus licheniformis DSM
5749), when used as a feed additive for piglets, pigs for fattening, sows, turkeys for fattening and
calves (category: zootechnical additives; functional group: gut ﬂora stabilisers). During the assessment,
the applicant requested to extend the application period for sows from the one currently authorised
(“from 2 weeks before farrowing and during the lactation”) to the whole reproductive cycle.
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive) and under Article 10(2) (re-evaluation
of an authorised feed additive). EFSA received directly from the applicant the technical dossier in
support of this application. The particulars and documents in support of the application were
considered valid by EFSA as of 7 July 2010.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product BioPlus 2B® (Bacillus subtilis DSM 5750 and Bacillus licheniformis DSM 5749), when used
under the proposed conditions of use (see Section 3.1.3).
1.2. Additional information
The additive BioPlus 2B®3 is a preparation of B. subtilis (DSM 5750) and B. licheniformis (DSM
5749). The Scientiﬁc Committee on Animal Nutrition (SCAN) issued two opinions on the use of
BioPlus® 2B as a feed additive (European Commission, 1997, updated 2003, and European
Commission, 2000). EFSA has issued several opinions on the compatibility of BioPlus 2B with
coccidiostats (EFSA, 2003, 2005, 2006, 2007, 2008 and EFSA FEEDAP Panel, 2011a) and one opinion
on the use of the additive with sows (EFSA FEEDAP Panel, 2011b).
The additive is currently authorised for use in feed for pigs for fattening and piglets,4 sows,5
turkeys for fattening and calves.6 With the current application, the applicant is requesting the re-
evaluation of the additive administered through feed and the new authorisation for use in water for
drinking. The additive subject of the authorisation is BioPlus 2B® 10 in a formulation which is 10-fold
more concentrated than the formulation currently authorised.
The bacterial species B. licheniformis and B. subtilis are considered by EFSA to be suitable for the
qualiﬁed presumption of safety (QPS) approach to safety assessment (EFSA, 2007, EFSA BIOHAZ
Panel 2013). This approach requires the identity of the strains to be conclusively established and
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Chr. Hansen A/S, 10-12 Boege Alle, 2970 Hoersholm, Denmark.
3 The Applicant intends to market the product also under the tradename Nemix.
4 Commission Regulation (EC) No 2148/2004 of 16 December 2004 concerning the permanent and provisional authorisations of
certain additives and the authorisation of new uses of an additive already authorised in feedingstuffs. OJ L 370, 17.12.2004, p. 24.
5 Commission Regulation (EC) No 1453/2004 of 16 August 2004 concerning the permanent authorisation of certain additives in
feedingstuffs. OJ L 269, 17.8.2004, p. 3.
6 Commission Regulation (EC) No 600/2005 of 18 April 2005 concerning a new authorisation for 10 years of a coccidiostat as an
additive in feedingstuffs, the provisional authorisation of an additive and the permanent authorisation of certain additives in
feedingstuffs. OJ L 99, 19.4.2005, p. 5.
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evidence that the strains lack of toxigenic potential and do not show resistance to antibiotics of human
and veterinary importance.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier7 in support of the authorisation request for the use of BioPlus 2B® (B. subtilis DSM 5750 and
B. licheniformis DSM 5749) as a feed additive. The technical dossier was prepared following the
provisions of Article 7 of Regulation (EC) No 1831/2003, Regulation (EC) No 429/20088 and the
applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active agents in animal feed. The Executive Summary of the EURL
report can be found in Annex A.
2.2. Methodologies
The approach followed by the EFSA Panel on Additives and Products or Substances used in Animal
Feed (FEEDAP) to assess the safety and the efﬁcacy of BioPlus 2B® is in line with the principles laid
down in Regulation (EC) No 429/2008 and the relevant guidance documents: Guidance on
zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical guidance: Tolerance and efﬁcacy studies
in target animals (EFSA FEEDAP Panel, 2011c), Guidance on studies concerning the safety of use of
the additive for users/workers (EFSA FEEDAP Panel, 2012b), Guidance on the assessment of the
toxigenic potential of Bacillus species used in animal nutrition (EFSA FEEDAP Panel, 2014), Technical
Guidance: microbial Studies (EFSA, 2008), and Guidance on the assessment of bacterial susceptibility
to antimicrobials of human and veterinary importance (EFSA FEEDAP Panel, 2012c).
3. Assessment
The additive BioPlus 2B® is a preparation of B. subtilis (DSM 5750) and B. licheniformis (DSM
5749) intended for use with piglets (suckling and weaned), pigs for fattening, sows to have beneﬁts in
piglets, turkeys for fattening and calves for rearing (category: zootechnical additives; functional group:
gut ﬂora stabilisers).
3.1. Characterisation
3.1.1. Characterisation of the active agents
The B. licheniformis strain was originally isolated from soil and the B. subtilis strain from soy bean
mash.9 They are deposited in the Deutsche Sammlung von Mikro-organismen und Zellkulturen, under
the accession numbers DSM 5749 (B. licheniformis) and DSM 5750 (B. subtilis).10
The identiﬁcation of B. licheniformis DSM 5749 was achieved by analysing the partial gyrA and rpoB
sequences. B. subtilis DSM 5750 was identiﬁed using multilocus sequence analysis comparing the
partial sequences of groEL, gyrA, polC, purH and rpoB.11 The strains have not been genetically
modiﬁed. Strain-speciﬁc identiﬁcation and genetic stability analysis are based on the use of pulsed ﬁeld
gel electrophoresis (PFGE) after cleavage with restriction enzymes used individually.12 Using this
method, the master culture is compared with the working cultures used to inoculate fermentation
batches. No differences in the resultant patterns have been observed to date.
Cytotoxicity of the two strains was assessed on Vero cells using the culture supernatants in
accordance to the FEEDAP Panel guidance document (EFSA FEEDAP Panel, 2014). Neither strain was
7 FEED dossier reference: FAD-2009-0023.
8 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
9 Technical dossier/Section II.
10 Technical dossier/Section II/Annex II.2.1.2a.
11 Technical dossier/Section II/Supplementary information September 2012/Annex 5.
12 Technical dossier/Section II/Supplementary information September 2012/Annex 6.
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shown to be toxigenic.13 A sperm mobility test with a water/methanol extracts did not signiﬁcantly
reduce the motility of spermatozoa.14,15 Both strains are non-haemolytic when tested on blood agar
plates for 72 h.16
Both strains were tested for antibiotic susceptibility using twofold broth dilutions. The battery of
antibiotics tested was that recommended by EFSA (EFSA FEEDAP Panel, 2012c).17 All minimum
inhibitory concentration (MIC) values for the B. subtilis strain fell below the corresponding cut-off
values deﬁned by the FEEDAP Panel. The MIC values for B. licheniformis DSM 5749 were equal or fell
below the corresponding cut-off values deﬁned by the FEEDAP Panel, with the exception of
streptomycin (16 vs 8 mg/L). This is within the normal variation around the mean, and thus, does not
raise concerns for safety.
3.1.2. Characterisation of the additive
BioPlus 2B® 10 is a 1:1 mixture of the two active agents, B. licheniformis DSM 5749 and B. subtilis
DSM 5750, with a minimum content of spores in the additive of 3.2 9 1010 colony forming units (CFU)/g.
The carrier materials include calcium carbonate (92%) and 1% of kieselgur18 as anticaking agent.19
Data on ﬁve batches of BioPlus 2B® 10 showed that the minimum speciﬁcation was exceeded in all
samples (mean value 4.2 9 1010 CFU/g, range 3.8–4.8 9 1010 CFU/g) and that the 1:1 ratio between
B. licheniformis and B. subtilis was complied with in all the analysed batches.20
The additive is routinely monitored for microbial and chemical contamination at various points in
the manufacturing process and in the ﬁnal product. Limits are set for total coliforms (< 100 CFU/g),
Escherichia coli (< 10 CFU/g), yeasts and ﬁlamentous fungi (< 100 CFU/g), and Salmonella (absent in
25 g). Analysis of ﬁve batches of the additive demonstrated compliance with these limits.21 Apparently,
no speciﬁcations are set for undesirable substances but the applicant declares that levels are in
accordance with legal limits, when these exist. The analysed values on three batches (mean values:
aﬂatoxin B1 < 0.64 lg/kg, mercury 0.01 mg/kg, lead 0.44 mg/kg, cadmium 0.11 mg/kg, arsenic
0.87 mg/kg, and dioxins and polychlorinated biphenyls (PCBs): octachlorodibenzo-p-dioxin (OCDD)
< 0.198 ng/kg, octachlorodibenzofuran (OCDF) < 0.208 ng/kg, WHO-polychlorinated dibenzodioxins/
dibenzofurans-toxic equivalent (WHO-PCDD/F-TEQ) < 0.241 ng/kg and WHO-PCDD/F-PCB-TEQ
< 0.255 ng/kg) do not raise concerns.22
One batch of BioPlus 2B® 10 was examined for particle size distribution by laser diffraction and
dusting potential with a Heubach dustometer.23 Results showed that 8.7% by volume of the additive
consists of particles with diameters below 50 lm and 4.5% below 10 lm. The value for dusting
potential was 6.3 g/m3, which is considered high.
3.1.3. Manufacturing process24
The manufacturing process is detailed in the dossier.25
3.1.4. Stability and homogeneity
Most of the studies presented were performed with BioPlus 2B®, the currently authorised form. As
the bacterial counts are independent of the form of the additive, these results are considered to
equally apply to BioPlus 2B® 10.
13 Technical dossier/Section II/Annex II.2.2.2c.
14 Technical dossier/Section II/Annex II.2.2.2a.
15 Technical dossier/Section II/Supplementary information September 2012/Toxigenic potential/Annex 3.
16 Technical dossier/Section II/Supplementary information September 2012/Annexes 1 and 5.
17 Technical dossier/Section II and Supplementary information September 2012/Annexes II.2-8 and 8.
18 Currently under re-evaluation according to Article 10(2) of Regulation (EC) No 1831/2003 of the European Parliament and of
the Council of 22 September 2003 on additives for use in animal nutrition. OJ L 268, 18.10.2003, p. 29.
19 Technical dossier/Section II and Supplementary information September 2012/Overview of Q and answers.
20 Technical dossier/Section II/Annex II.1.3b.
21 Technical dossier/Supplementary information April 2014/Annexes II.1.3b, II.1.4.1a and b.
22 Technical dossier/Section II/Annex II.1.4.1.
23 Technical dossier/Supplementary information September 2012/Annexes 3 and 4.
24 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
25 Technical dossier/Section II.
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3.1.4.1. Shelf life
Three studies were provided with a total of six batches of BioPlus 2B® to support the shelf life at 5,
20–25 and 37°C.26 Total counts of bacilli and differential enumeration of the two species remained
unvaried (< 0.5 log) over 36 months at temperature equal or lower than 20–25°C. The shelf life of the
more concentrated form (BioPlus 2B® 10) is not expected to differ. This was conﬁrmed by stability
studies made with the concentrated cell mass (intermediate product containing 2.5 9 1011 CFU/g)
which showed similar viability over time.
3.1.4.2. Stability in premixtures and feed
Stability of three batches of BioPlus 2B® when mixed with a minerals/vitamins premixture
(containing choline chloride) for sows was tested at 25°C for 3 months.27 No signiﬁcant differences in
the total counts of bacilli and differential enumeration of the two species were observed. An additional
study with premixtures for calves at 25°C for 4 months, performed on ﬁve subsamples, conﬁrmed the
stability of the product over this period. However, none of the studies extended to 6 months.
The stability of BioPlus 2B® to pelleting conditions (75, 85 and 95°C) was tested when mixed with
piglets’ feed in two studies.28 The enumeration of total counts of bacilli showed a recovery close to
80% after the thermal treatment, regardless of the process temperature. In a different study, the total
counts and the differential enumeration of the two species showed a recovery higher than 87% after a
pelleting at 84°C for 10 minutes.
The stability of several batches of BioPlus 2B®, when mixed with pelleted feeds for piglets, pigs for
fattening, sows and poultry at the recommended dose was tested. No signiﬁcant differences in the
total counts of bacilli and differential enumeration of the two species were observed up to 16 months
at 20–25°C.29
The stability of BioPlus 2B® suspended in water for drinking at 25°C was tested after 1, 2 and
7 days. Total recovery after 7 days was over 90% with both strains showing equal stability.30
3.1.4.3. Homogeneity
The capacity of the additive to homogeneously distribute in feed was studied using the current
authorised product BioPlus 2B®. One batch of BioPlus 2B® was incorporated into a mash feed and a
second batch into a feed prior to pelleting (type not speciﬁed) at the recommended dose.31 In both
cases, eight subsamples were taken from the product stream during the packaging process. Analyses
of total counts showed a coefﬁcient of variation (CV) of 9% for the mash feed and 11% for the
pelleted feed.
3.1.5. Conditions of use
BioPlus 2B® 10 is intended for use in feedingstuffs and water for drinking for suckling and weaned
piglets until 35 kg, pigs for fattening, sows during the whole reproductive cycle, turkeys for fattening and
calves until 3 months of age. The minimum recommended dose for use in feed is 1.3 9 109 CFU/kg
feed. The minimum dose proposed by the applicant for use in water for drinking is 6.4 9 108 CFU/L
water for pigs, 6.3 9 108 CFU/L water for turkeys and 6.6 9 108 CFU/L water for calves.32
3.2. Safety
3.2.1. Safety for the target species, consumer and the environment
In the view of the FEEDAP Panel, the identity of the production strains (DSM 5750 and DSM 5749)
is established as B. licheniformis and B. subtilis, respectively. Moreover, the toxigenic potential and the
antibiotic resistance qualiﬁcations have been met. Therefore, they are presumed safe for the target
species, consumer of products fed with the additive and the environment.
26 Technical dossier/Section II/Annexes II_4_1a, Annexes II_4_1b and II_4_1g.
27 Technical dossier/Section II/Annexes II_4_1c and II_4_1e.
28 Technical dossier/Section II/ Annex II_4_1d.
29 Technical dossier/Section II/Annexes II_4_1d and II_4_1e.
30 Technical dossier/Supplementary information September 2012/Annex 9.
31 Technical dossier/Section II/Annex II_4_2a.
32 Technical dossier/Supplementary information September 2012/Annex 11.
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3.2.2. Safety for the user
No data are available on skin/eye irritation or skin sensitisation for the additive BioPlus 2B® 10. A
small fraction (9%) of the particles of the product has the potential to reach the respiratory surface of
the lungs when inhaled and the dusting potential measured is high. Given the proteinaceous nature of
the active agents, the additive should be considered to be a potential respiratory sensitiser.
3.3. Efﬁcacy
The studies presented were performed with BioPlus 2B®, the currently authorised form. The
FEEDAP Panel considers that results of the efﬁcacy studies apply to all forms of the additive when
delivering the same dose in terms of CFU/kg feed.
3.3.1. Efﬁcacy for sows
The current authorisation of BioPlus 2B® for sows covers the period from 2 weeks before farrowing
until weaning. The applicant has now requested the authorisation of BioPlus 2B® 10 in sows covering
the whole reproduction cycle.
In 2011, the FEEDAP Panel already evaluated the extension of the use of the additive from 2 weeks
before farrowing until weaning to the whole reproductive cycle of sows (EFSA FEEDAP Panel, 2011b).
In that instance, the applicant provided ﬁve efﬁcacy trials, one covering two reproductive cycles, two
covering one reproductive cycle and two covering the period ‘2 weeks before farrowing and lactation’.
The latter two studies were not considered because they did not cover the full period under
evaluation. The aim of the three remaining studies, performed in two Member States, was to evaluate
the efﬁcacy of BioPlus 2B® on sow reproductive characteristics with special emphasis on the beneﬁts
for the piglets (weight gain and mortality). In all trials, the animals were randomly allocated to the
experimental groups in order to make the reproductive and physiological status between groups as
homogenous as possible. Tests on all feed batches used in the trials conﬁrmed that the correct
inclusion rate of spores was applied (1.3 9 109 CFU/kg feed). The animals were fed either a dry sow
diet or a lactation diet according to the periods of the reproductive stage. In all trials, zootechnical
parameters were recorded for sows (weight, feed intake) and piglets (weight, mortality). Data from
each experiment were submitted to analysis of variance (ANOVA). The statistical unit was the sow for
all the variables.
The FEEDAP Panel, based on the data provided, concluded the following: ‘Three trials were
provided covering at least one reproductive cycle. Although, one study showed reduction in piglet
mortality, numbers of weaned piglets and litter weight at weaning were unaffected in all studies.
Therefore, the FEEDAP Panel ﬁnds insufﬁcient evidence of any beneﬁt when sows are treated with
BioPlus 2B® over the entire reproductive period’ (EFSA FEEDAP Panel, 2011b). The results of the
studies previously assessed are described in Table 1 (studies 1–3).
A new study (No 4 in Table 1) was submitted involving 46 sows (PIC 1050/C29) allocated to two
treatments at the time of breeding (control and BioPlus 2B® treated animals (1.3 9 108 CFU/kg feed))
based on weight and parity.33 Sows were individually fed standard gestating and lactating diets in meal
form. The study lasted one complete cycle. Litters size was standardised by moving average sized pigs
to non-study sows. Piglets did not have access to creep feed or supplemental milk during the course of
the assessment. Parameters measured were: sows weight (at breeding, week 8 of gestation, at
farrowing and day 18 of lactation), body condition (at breeding, week 8 of gestation, at farrowing and
after 18 days) and feed intake, piglets per litter, litter weight at birth and at weaning, mortality and
morbidity. Data were analysed by an ANOVA with main effects of treatment and parity. Mortality was
analysed using a one-way non-parametric method.
The results of the four studies are summarised in Table 1.
33 Technical dossier/Supplementary information September 2012/Annex 25.
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The only consistent response seen was a reduction in mortality of piglets, however, this reached
signiﬁcance in only one study. The applicant, after having checked for homogeneity, performed a
meta-analysis pooling the data of the four studies (number of piglets per litter born, born alive,
stillbirth, mummiﬁed and weaned, piglet loss during lactation (after cross-fostering), mortality rate and
weight of piglets at birth) taking into account the effect of the trial and the BioPlus 2B® inclusion with
a non-linear link function (log function) analysis.34 As mortality rate did not follow a normal
distribution, this variable was investigated using the non-parametric Wilcoxon test. The experimental
unit was the sow for all parameters. This analysis resulted in a signiﬁcant decrease of mortality in the
BioPlus 2B® group compared with the control (14.4% vs 10.4%, p = 0.002). The number of stillborn
piglets (1.3 vs 1.0, p = 0.05) was also signiﬁcantly reduced by treatment in the BioPlus 2B® group
compared with the control. The other parameters were not inﬂuenced by the addition of the additive
(number of piglets born: 15.0 vs 14.2; number of piglets born alive: 13.2 vs 12.8; piglet weight at
birth: 1.41 vs 1.45 kg).
It can be concluded that the additive has the potential to reduce mortality of piglets when given to
sows over the whole reproductive cycle at the minimum dose of 1.3 9 109 CFU/kg feed.
3.3.2. Efﬁcacy for piglets
A total of 19 studies were submitted to demonstrate the efﬁcacy of BioPlus 2B® in piglets. Some
involved animals from birth and others from weaning.
3.3.2.1. Efﬁcacy for suckling and weaned piglets
The ﬁrst four studies were performed in three Member States and involved piglets during the
suckling and post-weaning period. A ﬁfth study35 could not be further considered due to ﬂaws in the
statistical approach (i.e., inadequate experimental unit).
All studies shared the same experimental design with sows (Topig 40 dams in trial 1,36 Large White
9 Landrace in trial 2,37 DanBred in trial 338 and Large White 9 Landrace in trial 439) allocated to two
treatments to obtain homogeneous groups based on parity and body condition/weight. Sows were fed
pelleted lactation feed from farrowing until weaning of piglets which was around 28 days of age in
trials 1 and 3, 26 in trial 2 and 27 in trial 4. Cross-fostering was carried out within treatments and
within 1 day after farrowing. Suckling piglets had access to feed without (control) or with BioPlus 2B®
Table 1: Overview of results of efﬁcacy studies with BioPlus 2B® in sows during a full reproductive cycle
No. sows/
treatment
Dose
(CFU/kg
feed)
Number of piglets/litter Litter weight
Piglet
mortality(4)
(%)
Born
alive
Born dead
and
mummiﬁed
After
cross-
fostering(1)
Weaned
After cross-
fostering(2)
(kg)
At
weaning(3)
(kg)
24
24
0
1.3 9 109
11.9
10.6
1.6
1.0
11.9
11.2
10.2
10.4
17.4
16.9
78.1
85.4
13.8b
7.3a
42
43
0
1.3 9 109
14.0
14.2
2.5
1.6
12.3
12.5
11.6
12.0
25.6
26.0
82.0
81.7
14.6
9.6
35
35
0
1.3 9 109
12.6
12.0
3.0
2.6
11.0
11.0
10.6
10.5
23.2
22.2
64.2
61.5
15.6
12.1
23
23
0
1.3 9 109
13.2
12.8
1.1
1.1
12.7
12.5
11.0
11.2
19.0
19.0
75.6
75.2
13.5
10.6
CFU: colony forming units.
a,b: Means in a column within a given trial with different superscript letters are signiﬁcantly different p < 0.05.
(1): At day 5 in studies 2 and 3.
(2): At birth in study 1.
(3): At 21 days in studies 3 and 4.
(4): Number of pigs dying during lactation expressed as a percentage of live births (adjusted for fostering).
34 Technical dossier/Supplementary information September 2012/Annex 25 Metaanalysis.
35 Technical dossier/Section IV and Supplementary information September 2012/Annexes IV_3_1: Annexes Piglet trial eff. Ref. 08
and 15-17.
36 Technical dossier/Supplementary information January 2016/3.1.Piglets suckling + weaned/Annex_IV.3.1.15.
37 Technical dossier/Supplementary information January 2016/3.1.Piglets suckling + weaned/Annex_IV.3.1.16.
38 Technical dossier/Supplementary information January 2016/3.1.Piglets suckling + weaned/Annex_IV.3.1.17.
39 Technical dossier/Supplementary information January 2016/3.1.Piglets suckling + weaned/Annex_IV.3.1.18.
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at 1.3 9 109 CFU/kg from day 1. They continued receiving the dietary treatments after weaning for
42 days. The dose was conﬁrmed by analysis of feed. Diets were is mash form and based on wheat/
rice/ﬁshmeal/whey protein in the suckling period and on barley/maize/wheat/rice/soybean meal in the
post-weaning period. At weaning, litters were kept together with each litter in a single pen (except in
study 3 where 2 litters were grouped in a single pen). The studies ended 42 days post-weaning, when
piglets were approximately 67–70 days of age. Piglets were weighed at day 1 of life, at weaning and
at 14, 28 and 42 days post-weaning. Morbidity and mortality were also monitored. Data were analysed
using an ANOVA with the farrowing pen of one sow/litter as the experimental unit in the lactation
phase and the pen (containing approximately, 13 piglets in the ﬁrst three studies and 11 in the last)
during the post-weaning phase. A summary of the results is presented in Table 2.
Study 1 did not show any signiﬁcant result either during the suckling period or the post-weaning
period. In study 2, the average daily gain (ADG) was signiﬁcantly improved in BioPlus 2B® treated
animals only in the post-weaning period. In study 3, growth and feed to gain ratio during the post-
weaning period were signiﬁcantly improved in treated piglets. In study 4, the mortality of piglets
during the suckling period only was signiﬁcantly reduced in treated animals without any changes in
other zootechnical parameters. In the only two studies in which some performance parameters were
reported (ADG and mortality in study 1, ADG in study 3) in the overall period (suckling + post-
weaning), these were not signiﬁcantly inﬂuenced by treatment (in study 1, ADG: control = 379 g/day
vs BioPlus 2B® = 386 g/day; p = 0.498 and mortality: control = 12.4% vs BioPlus 2B® = 11.5%,
p = 0.803; study 3, control = 374 g/day vs BioPlus 2B® = 396 g/day, p = 0.084).
After having checked for homogeneity, a meta-analysis was applied to the four studies reporting
only the data on weight gain at various periods from birth to 42 days post-weaning.40 Although some
beneﬁts were observed in an intermediate period (during suckling + 28 days post-weaning), no
signiﬁcant effects on ADG were seen at the end of the suckling period (235 vs 239 g/day) or at
42 days post-weaning (438 vs 449 g/day) or when both periods were combined (355 vs 364 g/day).
Based on these four studies, there is insufﬁcient evidence to conclude on the efﬁcacy of BioPlus
2B® when supplemented at the recommended dose to piglets during the suckling and post-weaning
period.
Table 2: Overview of results of efﬁcacy studies with BioPlus 2B® in suckling and weaned piglets
Study
(duration
in days)
Total
number of
piglets
entering
the study
Replicates/
treatment
3 piglets/
replicate
BioPlus
2B®
(CFU/kg
feed)
Suckling period Post-weaning period
Initial
weight
(kg)
Feed
intake(3)
(g/day)
Final
weight
(kg)
Average
daily
gain
(g/d)
Feed:
gain
Mortality
and culls
(%)
Feed
intake
(g/day)
Average
daily
gain
(g/d)
Feed:
gain
Mortality
(%)
Final
weight
(kg)
1
(70)
624
24 9 13
0
1.3 9 109
1.47
1.49
82
81
8.08
8.09
235
233
0.35
0.35
6
6
875
863
495
504
1.79
1.72
6
6
27.6
28.1
2
(68)
351(1)
16 9 13
0
1.3 9 109
1.52
1.55
51
61
7.75
8.09
240
252
– 8
14
520
553
376a
400b
1.39
1.38
5
7
23.6a
24.9b
3
(70)
639
24 9 13
0
1.3 9 109
1.44
1.47
6.83
7.50
7.18
7.43
233
240
– 12
12
721
734
454a
484b
1.59b
1.52a
8
4
26.5a
28.0b
4
(69)
340(2)
16 9 11
0
1.3 9 109
1.62
1.73
76
71
7.80
7.93
232
234
– 18b
8a
561
556
400
390
1.41
1.43
4
4
24.6
24.3
CFU: colony forming units.
a,b: Means in a column within a given trial with different superscript letters are signiﬁcantly different p < 0.05.
(1): 176 control/175 BioPlus 2B®.
(2): 171 control/169 BioPlus 2B®.
(3): In study 3, total feed intake kg/litter (sum of creep feed fed from day 1–14 and prestarter feed (mix of creep feed and milk replacer)
fed from day 15 until weaning).
40 Technical dossier/Supplementary information January 2016/3.1.Piglets suckling + weaned/Annex_IV.3.1.19.
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3.3.2.2. Efﬁcacy for weaned piglets
Fourteen reports of feeding trials performed in several Member States and involving piglets from
weaning were submitted. However, 11 studies41 were not considered due to insufﬁcient reporting and/or
ﬂaws in the experimental design and analysis (e.g. insufﬁcient duration, inappropriate production stage
of animals, inadequate statistical unit). Results of the three remaining studies fulﬁlling the minimum
requirements are described below.
The detailed design of the studies is presented in Table 3 and the results in Table 4. In all cases (studies
142 and 243 and 344), piglets (same number of females and males) were distributed in two experimental
groups, one receiving the basal diets not supplemented and a second receiving the basal diets supplemented
with the additive in order to provide 1.3 9 109 CFU/kg feed. Intended cell counts were conﬁrmed by
analysis. In study 1, BioPlus 2B® supplementation started at least 10 days before weaning. The diets were
offered to the animals ad libitum. Health status was monitored throughout the experimental periods
(incidence of diarrhoea was monitored in study 1). Feed intake and body weight of the animals was
measured and the feed to gain ratio was calculated. In all studies, an ANOVA was performed on the data
obtained using the pen as the experimental unit. In study 2, the initial body weight was introduced as a
covariate.
Table 3: Details on the study design for the studies performed in weaned piglets
Study
Breed
(Age in days)
(Sex)
Total animals
Replicates/
treatment 3
animals/
replicate
Duration of
the study
(days)
Basal diets
(Main ingredients)
Form
1 German Landrace
(23)
♀,♂
946
10 9 47/48
48 Prestarter and starter
(Wheat/soybean meal/maize/ﬁsh meal/
skimmed milk powder)
Pellet
2 Pietrain 9 ACMC
(28)
♀,♂
144
12 9 6
42 Prestarter and starter
(Maize/sweet dried milk whey/soybean/
barley)
Mash
3 (Belgian Landrace 9
Hampshire) 9 (Large White
9 Landrace)
(28)
♀,♂
540(a)
12 9 15–29
42 Prestarter and starter
(Maize/soybean meal/wheat bran/ﬁsh
meal)
Mash
(a): 252 in the control group (1 replicate of 15 animals, 1 of 16, 1 of 20, 4 of 21, 1 of 22, 1 of 23 and 3 of 24) and 288 in the
treated group (1 replicate of 17 animals, 1 of 18, 1 of 20, 1 of 21, 2 of 24, 1 of 26, 3 of 27, 1 of 28 and 21 of 29).
Table 4: Overview of results of efﬁcacy studies with BioPlus 2B® in weaned piglets
Study
BioPlus 2B
(CFU/kg feed)
Initial
weight(1)
(kg)
Final
weight
(kg)
Feed
intake
(g/d)
Average daily
gain (g/d)
Feed:gain
Mortality
(%)
1 0
1.3 9 109
6.5
6.4
23.8
25.0
729
731
359a
389b
2.03b
1.88a
1
2
2 0
1.3 9 109
8.2
8.2
24.1
24.7
588
613
375a
403b
1.54
1.52
0
3
3 0
1.3 9 109
6.9
6.9
24.0a
25.3b
614
605
406a
425b
1.50b
1.38a
7b
4a
CFU: colony forming units.
a,b: Means in a column within a given trial with different superscript letters are signiﬁcantly different p ≤ 0.05.
(1): In study 1, BioPlus 2B® supplementation started at least 10 days before weaning.
41 Technical dossier/Section IV and Supplementary information September 2012/Annexes IV_3_1: Piglet trial eff. Ref. 01, Piglet trial
eff. Ref. 03, Piglet trial eff. Ref. 04, Piglet trial eff. Ref. 05, Piglet trial eff. Ref. 06, Piglet trial eff. Ref. 07, Piglet trial eff. Ref. 10,
Piglet trial eff. Ref. 11, Piglet trial eff. Ref. 12, Piglet trial eff. Ref. 08 and Annexes 15-17 and Piglet trial eff. Ref. 09 and 18-21.
42 Technical dossier/Section IV and Supplementary information September 2012/Annexes IV_3_1: Piglet trial eff. Ref. 02 and 12-14.
43 Technical dossier/Supplementary information September 2012/Annex 22.
44 Technical dossier/Supplementary information September 2012/Annex 23.
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Weight gain was consistently increased and feed to gain ratio improved in animals receiving feed
supplemented with BioPlus 2B® in three or two studies, respectively. No other parameter was
inﬂuenced by treatment, except mortality in study 3 that was signiﬁcantly reduced in the BioPlus 2B®
group compared with the control.
It can be concluded that supplementation of BioPlus 2B® at the recommended dose has the
potential to improve performance of weaned piglets.
In addition, taking account of the studies in which BioPlus 2B® was provided during both suckling
and weaned periods, and the results of study 1 above in which BioPlus 2B® was provided 10 days
prior to weaning, the FEEDAP concludes that the additive has the potential to improve weight gain in
piglets from birth to 42 days post-weaning.
3.3.3. Efﬁcacy for pigs for fattening
Reports of 13 feeding trials performed to investigate the efﬁcacy of BioPlus 2B® with pigs for
fattening were submitted. Of these, ﬁve studies45 were not considered due to ﬂaws in the
experimental design (e.g. inadequate period of application of the additive, insufﬁcient duration). A
further study46 could not be considered because of extensive veterinary interventions throughout the
trial, denoting poor health of animals. After having tested for homogeneity, the data from eight studies
were pooled together in a meta-analysis.47 However, this could not be considered as it included the
study excluded because of the veterinary interventions.
The designs of the remaining seven studies are presented in Table 5 and the results in Table 6. All
studies had two experimental groups, one receiving the basal diets not supplemented and a second
receiving the basal diets supplemented with the additive in order to provide 1.3 9 109 CFU/kg feed.
Intended cell counts were conﬁrmed by analysis of feed. Animals were distributed in pens so as to
have a homogeneous distribution based on body weights and gender. In all cases, there were the
same numbers of males and females, with mixed pens in studies 1, 3, 4 and single sex pens in studies
2 (eight pens per sex and treatment), 5 and 6 (six pens per sex and treatment) and 7 (29 pens of
males and 15 of females in the control group and 28 pens of males and 18 of females in the treatment
group). The diets were offered to the animals ad libitum. Health status was monitored throughout the
experimental periods. Feed intake and body weight of the animals were measured and the feed to
gain ratio was calculated. Morbidity and mortality were also monitored. In study 6, faecal scores were
visually measured and days in diarrhoea monitored. In all studies, data were analysed using an ANOVA
in a completely randomised block design using the pen as the experimental unit and with initial body
weight as a covariate in studies 1, 2, 3 and 5. In study 4, a one way-ANOVA and the Duncan’s test
were applied to the data using the pen as experimental unit.
Table 5: Details on the study design for the studies performed in pigs for fattening
Study
Breed
(sex)
Total animals
Replicates/
treatment 3
animals/replicate
Duration of the
study (days)
Basal diets
(Main ingredients)
Form
1(a) Dan Breed 9 Duroc
♀,♂
96
24 3 2
81 Starter and ﬁnisher
(Wheat/barley/maize/soybean
meal)
Pelleted
2(b) Pietrain 9 ACMC
♀,♂
384
16 3 12
70 Grower and ﬁnisher
(Barley/wheat/soy/maize)
Mash and pelleted
3(c) (Swedish Yorkshire sires 9
Swedish Yorkshire dams) 9
(Swedish Yorkshire dams 9
Hampshire sires)
♀,♂
294
17 3 7–10
70 Grower and ﬁnisher
(Wheat/barley/wheat bran/
rapeseed cake/soya bean meal)
Pelleted
45 Technical dossier/Section IV, Supplementary information September 2012 and Supplementary information April 14/Annexes
IV_3_2. Pigs for fat. eff. Ref 1, Pigs for fat. trial eff. Ref. 2, Pigs for fat. trial eff. Ref. 3, Annex 24 and IV.3.2.4.
46 Technical dossier/Supplementary information January 2016/3.2.Pigs for fattening/Annex IV.3.2.09.
47 Technical dossier/Supplementary information January 2016/3.2.Pigs for fattening/Annex_IV.3.2.15_Meta-analysis.
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The supplementation of the additive at the minimum recommended dose consistently led to an
increased weight gain and a better feed to gain ratio in the BioPlus 2B® group compared with the
control, reaching a statistical signiﬁcance in four or three studies, respectively. No other parameter was
inﬂuenced by treatment.
It can be concluded that supplementation of BioPlus 2B® at the recommended dose has the
potential to improve performance of pigs for fattening.
Table 6: Overview of results of efﬁcacy studies with BioPlus 2B® in pigs for fattening
Study
BioPlus 2B®
(CFU/kg feed)
Initial
weight
(kg)
Final
weight
(kg)
Total feed
intake
(kg/day)
Average
daily gain
(kg/d)
Feed:gain
Mortality and
removal (n)
1 0
1.3 9 109
29.3
28.3
111.2
112.0
2.54
2.52
1.02
1.04
2.50
2.44
0
0
2 0
1.3 9 109
29.7
29.7
76.4
77.4
1.54
1.51
0.67
0.68
2.31
2.22
1
4
3 0
1.3 9 109
32.6
32.2
107.3
107.5
2.63
2.65
1.07
1.09
2.34
2.33
3
1
4 0
1.3 9 109
30.8
30.7
100.2a
101.6b
2.39
2.37
0.87a
0.89b
2.79a
2.69b
4
1
5 0
1.3 9 109
23.0
23.0
111.4a
117.0b
2.18a
2.32b
0.92a
0.98b
2.37
2.37
0
0
6 0
1.3 9 109
24.3
24.3
114.6a
121.1b
2.70
2.73
0.79a
0.84b
3.45a
3.25b
0
0
7 0
1.3 9 109
28.2
27.8
110.7a
113.6b
2.04
2.03
0.73a
0.76b
2.78a
2.66b
2.4
2.1
CFU: colony forming units.
a,b: Means in a column within a given trial with different superscript letters are signiﬁcantly different p < 0.05.
Study
Breed
(sex)
Total animals
Replicates/
treatment 3
animals/replicate
Duration of the
study (days)
Basal diets
(Main ingredients)
Form
4(d) PIC
♀,♂
308
6 3 26–28
80 Grower and ﬁnisher
(Triticale/barley/soybean meal)
Mash
5(e) Topigs 20 9 Tempo
♀,♂
96
12 9 4
96 Grower and ﬁnisher
(Wheat/barley/soya/maize/
rapeseed)
Mash
6(f) Large White 9 Landrace
♀,♂
144
12 9 6
115 Grower and ﬁnisher
(Wheat/triticale/soy/sunﬂower/
rapeseed)
Mash
7(g) Topigs Talent 9 Topigs 40
♀,♂
1,980
44/46(h) 9 22
112 Grower and ﬁnisher
(Maize/soybean/sunﬂower/wheat/
ﬁsh meal)
Pelleted
(a): Technical dossier/Supplementary information April 2014 and January 2016/Annexes Sect.IV Efﬁcacy/Annexes IV.3.2.5 and
IV.3.2.13.
(b): Technical dossier/Supplementary information April 14/Annexes Sect.IV Efﬁcacy/Annex IV.3.2.6.
(c): Technical dossier/Supplementary information April 14/Annexes Sect.IV Efﬁcacy/Annex IV.3.2.7.
(d): Technical dossier/Supplementary information April 14/Annexes Sect.IV Efﬁcacy/Annex IV.3.2.8.
(e): Technical dossier/Supplementary information January 2016/3.2.Pigs for fattening/Annex IV.3.2.10.
(f): Technical dossier/Supplementary information January 2016/3.2.Pigs for fattening/Annex IV.3.2.11.
(g): Technical dossier/Supplementary information January 2016/3.2.Pigs for fattening/Annex IV.3.2.12.
(h): 44 in the control and 46 in the treated group.
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3.3.4. Efﬁcacy for turkeys for fattening
Seven trials were performed in six Member States aiming at investigating the effects of BioPlus 2B®
supplementation to turkeys for fattening.
The designs of the studies are presented in Table 7 and the results in Table 8. The studies shared a
similar experimental design in which 1-day-old birds were fed standard diets ad libitum in 3–5
consecutive phases. In all cases, studies included two experimental groups, one receiving the basal
diets not supplemented and a second receiving the basal diets supplemented with the additive in order
to provide 1.3 9 109 CFU/kg feed (doses were conﬁrmed by analysis). The parameters monitored
were: individual weight, feed intake (per pen), morbidity and mortality. Weight gain and feed to gain
ratio (per pen) were calculated thereof. In study 5, some carcass indicators (based on 72 birds, 36 per
treatment) were also monitored, and in study 6, faecal analyses (dry matter) were made. Data were
analysed using an ANOVA including treatment and replication as factors and considering the pen as
experimental unit for all parameters.
In two of the seven studies, there was some evidence of a positive effect of the inclusion of
BioPlus 2B® at the minimum recommended dose of 1.3 9 109 CFU/kg feed on growth or feed to
gain ratio. No other parameter was inﬂuenced by treatment other than some traits in the carcasses
quality in study 5 (e.g. thigh weight was increased and abdominal fat reduced in the BioPlus 2B®
group).
Table 7: Details on the study design for the studies performed in turkeys for fattening
Study
Breed
(Sex)
Total animals
Replicates/
treatment 3
animals/replicate
Duration of
the study
(days)
Basal diets
(Main ingredients)
Form
1(a) BIG 6
♂
600
6 9 50
112 (Wheat/maize/soybean groats)
Pelleted
2(b) BUT 6
♂
1,200
3 9 200
119 (Maize/wheat/soybean/ﬁsh meal)
Pelleted
Contain coccidiostat
3a(c)
3b
BUT 9
♀
♂
324
6 9 27
240
6 9 20
84
105
(Soybean meal/wheat/maize/ﬁeld peas)
Pelleted
Contain coccidiostat
4(d) BUT 9
♀
720
10 9 36
96 (Wheat/soy beans/maize)
Mash and pelleted
Contain coccidiostat
5(e) BUT 9
♀
900
18 9 25
105 (Maize/soybean meal/wheat)
Pelleted
6(f) BIG 6
♂
497(h)
10 9 16–33
112 (Wheat/maize/soybean meal)
Pelleted
Contain coccidiostat
7(g) Not speciﬁed
♀
300
10 9 15
84 (Wheat/soybean meal/sunﬂower meal)
Pelleted
(a): Technical dossier/Section IV and Supplementary information January 2016/IV_3_4_Ref. 1 and Annex no. IV.3.4.9.
(b): Technical dossier/Section IV and Supplementary information January 2016/Annex and IV_3_4_Ref. 2 and 1.Report
Stat.analysis_T2.
(c): Technical dossier/Section IV and Supplementary information January 2016/IV_3_4_Ref. 3 and Annex no. IV.3.4.10.
(d): Technical dossier/Section IV/IV_3_4_Ref. 4.
(e): Technical dossier/Section IV and Supplementary information January 2016/IV_3_4_Ref. 5 and Annex no. IV.3.4.11.
(f): Technical dossier/Section IV and Supplementary information January 2016/IV_3_4_Ref. 6 and Annex no. IV.3.4.12.
(g): Technical dossier/Supplementary information April 2014/Sect.IV Efﬁcacy/Annex IV.3.4.7 Turkey/1.Report turkeys.
(h): 252 in control and 245 in the treated group. Pens are: 1 of 16 animals, 1 of 20, 2 of 21, 1 of 22, 1 of 29, 2 of 30, 1 of 31
and 1 of 32 in the control and 1 of 19, 1 of 20, 2 of 21, 2 of 22, 2 of 29 and 2 of 31 in the treated group.
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The applicant provided three different meta-analyses: the ﬁrst was performed on the data of the
female turkeys (studies 3a, 4, 5 and 7), the second on the data of the male turkeys (studies 3b, 4, 5
and 7) and the third one on the data of all seven studies.48 The last one could not be considered as
the weight of the animals at 84 days of age (the only parameter tested) had not be measured in two
of the studies but determined by calculation, using the daily gain from the ﬁnal period (ADG days
79–105, study 3b) or an intermediate period (ADG days 63–91, study 2). Data were pooled and
analysed statistically; differences were considered signiﬁcant at a level of at least p < 0.05. An ANOVA
was performed using the pen as experimental unit. The models included the effect of the treatment,
trial location (and pen) and the gender (where relevant). The interaction between treatment and trial
location was also investigated and found to be not signiﬁcant. The model for females considered also
the effect of the initial body weight of the birds.
In females, a signiﬁcantly greater weight gain was found in BioPlus 2B® treated animals. In males,
no signiﬁcant differences were detected between groups.
Overall, there is insufﬁcient evidence to conclude on the efﬁcacy of BioPlus 2B® for turkeys for
fattening.
3.3.5. Efﬁcacy for calves for rearing
Three studies were performed in three Member States to investigate the effects of BioPlus 2B® on
the performance of calves.
In all cases, calves (Holstein Friesian, 12–25-days-old) were allocated to two treatments (control and
BioPlus 2B®). Animals were housed in individual boxes in study 1 (with groups of 5–6 animals sharing
a common trough for solid feed), individually in study 2 and in four boxes of 13 calves each in study 3
(Table 9). Study 1 lasted for 9 weeks, and studies 2 and 3 lasted for 8 weeks. BioPlus 2B® was
administered via the milk replacer and concentrate (each at 1.3 9 109 CFU/kg feed, doses conﬁrmed by
analysis). The parameters monitored were initial and ﬁnal individual weights, mortality and morbidity
(including incidence of diarrhoea). Average daily weight gain was calculated. Milk replacer intake was
recorded individually in all the studies. The intake of solid feed (concentrate and forage if fed to the calves)
was monitored individually in studies 2 and 3 and per group (sharing a trough) in study 1. Data were
analysed using an ANOVA in a randomised block design and considering the calf as experimental unit in
studies 2 and 3 and the replicate in study 1. In the last study, the initial weight was used as covariate.
Concentrate, hay and maize silage intake data were not statistically analysed in study 1, concentrate
intake was not statistically analysed in study 3. The results of the studies are summarized in Table 10.
Table 8: Overview of results of efﬁcacy studies with BioPlus 2B® in turkeys for fattening
Study
BioPlus 2B®
(CFU/kg feed)
Final body
weight (kg)
Feed intake
(g/day)
Weight gain
(g/day)
Feed:gain
Mortality(1)
(%)
1 0
1.3 9 109
14.1a
14.9b
344
341
125a
131b
2.74b
2.58a
4.0
4.3
2 0
1.3 9 109
15.9
16.1
332
331
133
134
2.32
2.28
3.2
4.5
3a
3b
0
1.3 9 109
0
1.3 9 109
6.8
6.8
12.5
12.6
180
179
268
275
79
79
117
120
2.29
2.26
2.29
2.29
3.7
4.9
4.2
5.0
4 0
1.3 9 109
9.0
9.1
191
190
93
94
2.05
2.02
6.1
4.4
5 0
1.3 9 109
8.9
9.0
286
290
84
85
3.48
3.50
2.2
1.3
6 0
1.3 9 109
13.9
14.1
320
316
123
124
2.60
2.53
3.9
3.8
7 0
1.3 9 109
7.4a
7.7b
173
177
87a
91b
1.94
1.90
6.7
8.0
CFU: colony forming units.
a,b: Means in a column within a given trial with different superscript letters are signiﬁcantly different p < 0.05.
(1): Including birds culled in studies 1, 4 and 7.
48 Technical dossier/Supplementary information January 2016/3.4 Turkeys/New statistical analysis.
BioPlus 2B® for pigs, turkeys and calves
www.efsa.europa.eu/efsajournal 15 EFSA Journal 2016;14(9):4558
Final weight and weight gain for the overall period were improved in the BioPlus 2B® group in all
studies; the differences in weight gain reaching signiﬁcance in two studies. No other parameter was
inﬂuenced by treatment.
It can be concluded that supplementation of BioPlus 2B® at the recommended dose has the
potential to increase the growth rate of calves for rearing.
3.3.6. Efﬁcacy in water
Based on a water to feed ratio of two, the dose of 6.5 9 108 CFU/L water would provide essentially
the same exposure as the dose currently authorised for use in feedingstuffs. Consequently, the
conclusions on efﬁcacy of the additive when used in feedingstuffs also apply to use in water for
drinking for weaned piglets, pigs for fattening, sows and turkeys for fattening and calves.
3.3.7. Conclusions on efﬁcacy
BioPlus 2B® has the potential to improve the performance of piglets from birth to the end of
weaning and during the weaning period alone. The additive also has the potential to improve
performance of pigs for fattening and calves for rearing when supplemented at a minimum dose of
1.3 9 109 CFU/kg complete feed (approximately 6.5 9 108 CFU/L water for drinking). The data
provided in sows show that the additive used over a complete reproductive cycle has the potential to
reduce mortality of piglets when supplemented at a minimum dose of 1.3 9 109 CFU/kg feed
(approximately 6.5 9 108 CFU/L water for drinking).
The FEEDAP Panel was unable to conclude on the efﬁcacy of BioPlus 2B® for turkeys for fattening.
Table 9: Details on the study design for the studies performed in calves for rearing
Study
Breed
(Sex)
Total animals
Replicates/
treatment 3
animals/
replicate
Duration
(days)
Feeding regime Parameters monitored
1(a) Holstein
Friesian
♂
62
6 9 5–6(d)
63 Milk replacer (125 g/L, av.
5.2 L/calf per day) and from the
second week also maize silage,
concentrate and lucerne hay
Individual weight, individual
milk replacer and solid feed
intake per replicate (silage, hay
and concentrate)
2(b) Holstein
Friesian
♀
64
32 9 1
56 Milk replacer (100 g/L, 4.5 L/calf
per day) twice a day and starter
concentrate
Individual weight, individual
milk replacer and solid feed
intake
3(c) Holstein
Friesian
♂
52
26 9 1
56 Milk replacer (126 g/L, av.
5.4 L/calf per day) twice a day
and starter concentrate.
Grass silage ad libitum
Individual weight (at the
beginning and end and at two
intermediate times), individual
feed intake (milk replacer and
concentrate only)
(a): Technical dossier/Section IV/IV_3_5_Ref. 1.
(b): Technical dossier/Section IV/IV_3_5_Ref. 2.
(c): Technical dossier/Section IV/IV_3_5_Ref. 3.
(d): Five boxes with ﬁve animals and one with six animals.
Table 10: Overview of results of efﬁcacy studies with BioPlus 2B® in calves for rearing
Study
BioPlus 2B® (CFU/kg milk
replacer and concentrate)
Initial weight
(kg)
Final weight
(kg)(1)
Daily weight gain
(g/d)
1 0
1.3 9 109
45.4
45.3
82.0a
87.7b
581a
674b
2 0
1.3 9 109
42.3
42.5
76.8a
79.7b
617a
664b
3 0
1.3 9 109
47.3
47.4
77.5
84.4
538a
659b
CFU: colony forming units.
a,b: Means in a column within a given trial with different superscript letters are signiﬁcantly different p < 0.05.
(1): Not statistically analysed in study 3.
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3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation49 and Good
Manufacturing Practice.
4. Conclusions
The active agents of BioPlus 2B® 10 have been identiﬁed as strains of B. licheniformis and B.
subtilis; they are susceptible to clinically relevant antibiotics and do not show toxigenic potential.
Consequently, they meet the qualiﬁcations required by the QPS approach and can be presumed safe
for the target species, consumers of products derived from animals fed the additive and the
environment.
In the absence of data, the FEEDAP Panel cannot conclude on the irritancy of the additive to skin
and eyes or its dermal sensitisation. The particle size and dustiness of BioPlus 2B® 10 indicated a
potential for users to be exposed via inhalation. Given the proteinaceous nature of the active agents,
the additive should be considered as a potential respiratory sensitiser.
BioPlus 2B® and BioPlus 2B® 10 are considered equivalent when used to deliver the same dose.
BioPlus 2B® has the potential to improve performance of piglets (weaned and suckling plus weaned),
pigs for fattening, sows and calves for rearing at a minimum dose of 1.3 9 109 CFU/kg complete feed
or when used in water for drinking at an equivalent dose (6.5 9 108 CFU/L water). The data provided
in sows show that the additive has the potential to reduce mortality of suckling piglets when used over
a complete reproductive cycle. The FEEDAP Panel was unable to conclude on the efﬁcacy of BioPlus
2B® for turkeys for fattening.
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ANOVA analysis of variance
ADG average daily gain
bw body weight
CEN European Committee for Standardization
CFU colony forming unit
CV coefﬁcient of variation
EURL European Union Reference Laboratory
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed
LOD limit of detection
MIC minimum inhibitory concentration
OCDD octachlorodibenzo-p-dioxin
OCDF octachlorodibenzofuran
PCB polychlorinated biphenyls
PCDD polychlorinated dibenzo-p-dioxins
PFGE Pulsed Field Gel Electrophoresis
QPS qualiﬁed presumption of safety
sr standard deviation for repeatability
sR standard deviation for reproducibility
SCAN Scientiﬁc Committee on Animal Nutrition
TEQ toxic equivalent factor
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Annex A – Executive Summary of the Evaluation Report of the
Community Reference Laboratory for Feed Additives on the Methods of
Analysis for BioPlus 2B1
In the current application authorisation is sought for BioPlus 2B under the category ‘zootechnical
additives’, functional group ‘gut ﬂora stabiliser’ according to Annex I of Regulation (EC) No 1831/2003.
The product consists of two active substances, namely Bacillus subtilis DSM 5750 and Bacillus
licheniformis DSM 5749, mixed at a 1:1 ratio. Speciﬁcally, authorisation is sought for the feed additive to
be placed on the market in the powder form containing minimum concentration of 1.6 9 1010 CFU/g of
each strain. The intended use of the current application is for chickens for fattening, piglets for fattening,
sows, turkeys for fattening and calves. A total dosage including both strains of 1.3 9 109 CFU/kg in
complete feedingstuffs for all above mentioned species is proposed by applicant. Furthermore, the
applicant suggested a minimum content of BioPlus® 2B ranging from 11 to 270 g (depending of
the species) per 1,000 animals in drinking water. For the enumeration of the sum of the two strains of the
active agents in feed additive, premixtures, feedingstuffs and water the Applicant proposes the ring trial
validated a spread plate method (EN 15784) using tryptone soya agar. The performance characteristics
of the CEN method reported after logarithmic transformation of measured CFU values are:
• a standard deviation for repeatability (sr) ranging from 0.07 to 0.09 log10 CFU/g
• a standard deviation for reproducibility (sR) ranging from of 0.32 to 0.35 log10 CFU/g, and
• a limit of detection (LOD) of 105 CFU/kg of feedingstuffs.
Based on these performance characteristics, the CRL recommends for ofﬁcial control the ring trial
validated method EN 15784 for the determination of Bacillus subtilis DSM 5750 and Bacillus
licheniformis DSM 5749 in feed additive, premixtures, feedingstuffs and water.
Molecular methods were used by the Applicant for identiﬁcation of the active agent. The CRL
recommends for ofﬁcial control, Pulsed Field Gel Electrophoresis (PFGE), a generally recognised
standard methodology for microbial identiﬁcation.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
1 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/ﬁles/FinRep-FAD-2009-0023.pdf
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